Cardlytics (CDLX) to Release Quarterly Earnings on Wednesday

Cardlytics (NASDAQ:CDLXGet Free Report) is projected to announce its Q4 2025 results after the market closes on Wednesday, March 4th. Analysts expect the company to announce earnings of ($0.07) per share and revenue of $54.4560 million for the quarter. Interested persons can check the company’s upcoming Q4 2025 earning summary page for the latest details on the call scheduled for Wednesday, March 4, 2026 at 5:00 PM ET.

Cardlytics Price Performance

CDLX opened at $0.87 on Wednesday. Cardlytics has a 1 year low of $0.80 and a 1 year high of $3.28. The company’s 50 day simple moving average is $1.08 and its 200 day simple moving average is $1.38. The stock has a market capitalization of $46.95 million, a PE ratio of -0.41, a P/E/G ratio of 0.14 and a beta of 1.03. The company has a debt-to-equity ratio of 2.87, a quick ratio of 1.14 and a current ratio of 1.14.

Analysts Set New Price Targets

A number of equities analysts have weighed in on CDLX shares. Wall Street Zen lowered shares of Cardlytics from a “hold” rating to a “sell” rating in a report on Saturday, November 8th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Cardlytics in a research report on Monday, December 29th. Three analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Reduce” and an average price target of $2.25.

Read Our Latest Stock Report on Cardlytics

Insiders Place Their Bets

In related news, CEO Amit Gupta sold 45,159 shares of the stock in a transaction on Wednesday, February 18th. The stock was sold at an average price of $0.93, for a total value of $41,997.87. Following the completion of the sale, the chief executive officer directly owned 659,644 shares in the company, valued at approximately $613,468.92. This represents a 6.41% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Over the last three months, insiders have sold 117,875 shares of company stock worth $113,022. 4.40% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Cardlytics

Several institutional investors and hedge funds have recently modified their holdings of CDLX. XTX Topco Ltd raised its holdings in shares of Cardlytics by 143.5% during the 2nd quarter. XTX Topco Ltd now owns 85,971 shares of the company’s stock valued at $141,000 after buying an additional 50,663 shares during the period. Marshall Wace LLP acquired a new stake in Cardlytics in the second quarter valued at approximately $59,000. Jane Street Group LLC grew its position in Cardlytics by 263.0% in the second quarter. Jane Street Group LLC now owns 162,427 shares of the company’s stock valued at $267,000 after acquiring an additional 117,687 shares in the last quarter. Private Advisor Group LLC purchased a new stake in shares of Cardlytics during the third quarter valued at approximately $272,000. Finally, UBS Group AG lifted its position in shares of Cardlytics by 112.5% during the third quarter. UBS Group AG now owns 458,066 shares of the company’s stock worth $1,113,000 after purchasing an additional 242,536 shares in the last quarter. Hedge funds and other institutional investors own 68.10% of the company’s stock.

About Cardlytics

(Get Free Report)

Cardlytics, Inc operates a purchase intelligence and marketing platform that connects advertisers with consumers through bank and credit card transaction data. The company partners with financial institutions to analyze anonymized purchase information, enabling brands to deliver highly targeted offers and rewards directly to customers’ online and mobile banking channels. By leveraging real-time insights into consumer spending habits, Cardlytics helps marketers optimize campaign performance and measure return on ad spend more accurately than traditional digital advertising methods.

At the core of Cardlytics’ offering is its proprietary purchase intelligence engine, which aggregates and anonymizes transaction data from partner banks and credit unions.

Featured Articles

Earnings History for Cardlytics (NASDAQ:CDLX)

Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.